SorinRand believes that while high-quality lawyering is critical, it's not enough. When it comes to selecting trusted legal advisors, companies require businesspersons' pragmatism, results-oriented sensibility, creative and sophisticated solutions, and accessible and responsive service at fees they can afford.

Designed and built by leading lawyers from national law firms, SorinRand is committed to assisting startup, early-stage, emerging growth and middle market enterprises by helping to create and execute business strategies that reduce costs, increase efficiency, and maximize value.

Based on a paradigm shifting delivery model that avoids the over-leverage associated with the traditional law firm, SorinRand offers a unique combination of experienced lawyers at a sensible fee structure that is roughly half that of our national competitors.





 

SORINRAND is

a new law firm embracing and fostering a paradigm shift for 21st century business realities.  We are combining a commitment to the highest-quality lawyering with a businessperson’s practical, results-oriented sensibility to meet the needs of emerging growth, middle market, technology, and life science enterprises, as well as the investors, directors, and executives who support and lead them.  We offer creative and sophisticated solutions and accessible, responsive service by experienced lawyers, for highly competitive fees.

Latest News

  • CORPORATE LIVEWIRE – 2014 EMERGING GROWTH LAW FIRM OF THE YEAR – USA

     

    livewire_winner2014


    SorinRand is a law firm formed specifically to meet the business realties confronted by today’s entrepreneurs and innovators. Designed and built by leading lawyers from national law firms, SorinRand’s partners have long been recognized thought leaders with an impeccable reputation for addressing the unique needs of startup, early-stage, emerging growth and middle market technology and tech-enabled enterprises. As we approach our fifth anniversary we continue our commitment to help our clients create and execute business strategies that reduce costs, increase efficiency and maximize value.

    Our firm has positioned itself as counsel of choice for entrepreneurs, innovators, angel- and venture-backed companies, as well as the investors who support them, as evidenced by its high quality, highly regarded client base – comprised of hundreds of technology and tech-enabled companies, including 14 of the 100 fastest growing companies in our region, four of the 25 fastest growing companies in New Jersey, and 5 of the 80 hottest companies in New York, and more than a dozen venture capital firms, as well as angels, private equity funds and investment banks.

    The firm has achieved national acclaim, including Life Science Law Firm of the Year for both the US and North America, Emerging Growth Company Law Firm of the Year for the US, and Technology Law Firm of the Year for the US by the likes of Lawyer Monthly Magazine, Finance Monthly Magazine, Corporate LiveWire, Global Law Experts, and ACQ Finance.

    The recognition of the firm is a testament to its strength in representing entrepreneurial and technology companies. “Building on that strength, “ Sorin says, “we have renewed and deepened our commitment to creating client value through a lower-leverage delivery model and a competitive fee structure that is about half that of our national competitors.”


  • FOR IMMEDIATE RELEASE


    FIVE SORINRAND ATTORNEYS RECOGNIZED AS NEW JERSEY SUPER LAWYERS OR RISING STARS OF THE LEGAL PROFESSION

    David J. Sorin, Susan Okin Goldsmith, Nichole E. Martiak, Scott M. Smedresman and Lindsay M. Sorin Earn Prestigious Recognition

    EAST BRUNSWICK, NJ (March 17, 2014) – SorinRand LLP today announced prestigious awards to two of its partners, David J. Sorin, Managing Partner of the firm, and Susan Okin Goldsmith, Chair of the firm’s Technology Transactions Practice, who were named to the New Jersey Super Lawyers list. In addition, firm associates Nichole E. Martiak, Scott M. Smedresman and Lindsay M. Sorin have been named NJ Rising Stars of the legal profession.

    The NJ Super Lawyer list is comprised of not more than 5% of the lawyers in the state in about 70 practice areas recognized for their achievement of a high level of peer recognition and professional accomplishment based on peer nomination and evaluation as well as independent research. The NJ Rising Stars list is limited to lawyers who are 40 years old or less or have been in practice for 10 years or less and is comprised of no more than 2.5% of the lawyers in the state. The Rising Stars selection process mirrors that of NJ Super Lawyers. SorinRand is proud that five of its NJ-based attorneys have been honored for their outstanding work this year.

    “The selection of our lawyers, several of whom have been recognized in multiple years, for these prestigious awards is evidence of the value-added service that characterizes this firm. Our lawyers provide businesspersons’ pragmatism and sophisticated, creative solutions at a compelling value proposition to SorinRand’s client base. We are pleased with the recognition, and will continue to provide sensible solutions to start-up, emerging growth and middle market enterprises,” commented David J. Sorin, Managing Partner of SorinRand.

    David J. Sorin, a CPA and well known lawyer long serving NY, NJ and the mid-Atlantic region, is Managing Partner of SorinRand LLP, a law firm created to meet the new business realities to help clients achieve their goals, sensibly. Dave, previously named to the NJ Super Lawyers List and a finalist in the Ernst & Young 2012 Entrepreneur of the Year Awards, focuses primarily on privately-owned and publicly-traded emerging growth, technology and tech-enabled enterprises, as well as the investors, executives, and boards of directors who support and lead them. He has a long track record of successful representation of growth companies, having been repeatedly recognized for his unique combination of legal acumen and sound business judgment.

    Susan Okin Goldsmith, a nationally recognized trademark attorney, also was previously named to the NJ Super Lawyers List. Susan’s practice focuses on intellectual property, including global registration and enforcement strategy, domestic and foreign trademark clearance and registration, infringement matters, and intellectual property licensing. She is a long-time member of the Licensing Executives Society (LES) of the US and Canada, where she serves as co-chair on the Software Licensing Committee and participates on the Aerospace and Transportation Committee, and Consumer Electronics Committee, as well as with the local NJ Chapter, and is also a Certified Licensing Professional of the LES. Susan is

    featured in the World Trademark Review’s WRT 1000 for 2012 and 2013 - The World’s Leading Trademark Professionals, as a “recommended individual” in the State of New Jersey.

    An associate with the firm’s Intellectual Property Practice, Nichole E. Martiak joins the NJ Rising Stars for the second time. She devises value-added strategies and solutions; develops, maintains and manages patent portfolios; advises clients in regards to monetizing and licensing intellectual property; performs intellectual due diligence in transactional matters; and drafts licensing agreements. Nichole has extensive experience in: biotechnology; pharmaceuticals; food science; medical devices; as well as software methods; telecommunications; and computer technologies.

    Associate Scott M. Smedresman also joins the NJ Rising Stars for the second time. He focuses on corporate technology transactions and intellectual property-related agreements, in addition to trademark and copyright strategy, prosecution, enforcement and infringement. Scott advises clients on terms of use, privacy policies and end user licenses for website and mobile application.

    Lindsay M. Sorin, also an associate with the firm, makes her inaugural appearance on the NJ Rising Stars list. She advises both publicly traded and privately held entrepreneurial clients in a wide spectrum of technology-driven industries in the areas of employment law and executive compensation, general corporate, transactional, and securities law matters.  

    For more information about SorinRand, please visit www.sorinrand.com.

    ABOUT SORINRAND LLP

    SorinRand LLP is an award-winning law firm with offices based in East Brunswick, New Jersey, Manhattan, and

    Radnor, Pennsylvania. Led by a team of leading lawyers, SorinRand commits to high-quality lawyering and responsive service offered at a highly competitive rate. The firm’s paradigm-shifting model provides solutions and strategies for start-up, emerging growth and middle market sector technology and tech-enabled companies and the investors who support them. SorinRand works with clients from a wide spectrum of industries, including, but not limited to: technology; software; communications; marketing communications; alternative energy; nanotechnology; life science enterprise; technology-enabled industries; and finance. 

    ###


  • Christie Administration Approves $60 Million to Grow Tech/Bio Tech Industry in New Jersey 

    Program Spurs Economic Growth Statewide 

     

    Contact: New Jersey Economic Development Authority (609) 858-6685

    soliva@njeda.com 

     

    TRENTON, N.J. (Dec. 5, 2013) – In support of the Christie Administration's commitment to nurturing the growth of emerging technology and biotechnology businesses, the New Jersey Economic Development Authority (EDA) announced that 54 companies have been approved to share the $60 million allocation available through the State’s Technology Business Tax Certificate Transfer (NOL) Program in Fiscal Year 2014.

     

    This competitive program enables technology and biotechnology companies to sell New Jersey tax losses and/or research and development tax credits to raise cash to finance their growth and operations. Since the program was established in 1999, more than 490 different businesses have been approved for awards totaling $770 million. Each of the 54 applicants approved this year will receive an estimated $1.1 million which is a 21 percent increase from last year.

     

    "The NOL Program continues to be the most popular and the most effective support for these early stage companies,” said EDA Chief Executive Officer Michele A. Brown. "The Christie Administration understands that the success of the State’s greater technology industry is fundamentally tied to the growth of New Jersey’s economy. These companies have been able to raise capital and build their businesses in New Jersey as a result of this innovative program. This is exactly the kind of vital support this sector needs.”

     

    Administered by the EDA and the Department of Treasury's Division of Taxation, New Jersey- based technology or biotechnology companies with fewer than 225 U.S. employees may be eligible to sell net operating losses and research and development tax credits to unrelated profitable corporations for at least 80 percent of their value, up to a maximum lifetime benefit of $15 million per business.

     

    Companies that benefited this year include: New Brunswick-based Connotate, Inc., a tech company whose aim is to be the best in the world at Web data extraction and monitoring; Princeton Power Systems in Princeton, a designer and manufacturer of technology products for energy management, micro-grid operations and electric vehicle charging; Eagle Pharmaceuticals, a Woodcliff Lake-based pharmaceutical company which develops improved formulations of injectable products. Eagle has a development portfolio in excess of 15 products


    and currently has one marketed drug; their pipeline provides benefits to the healthcare community at large; and Agilence Inc., of Mount Laurel, an industry leader in the technology behind reporting solutions for retail loss prevention and operations. A full list of approved companies is attached.

     

    The Christie Administration has demonstrated an unprecedented commitment to growing business in New Jersey. The EDA is part of the state’s results-driven Partnership for

    Action. Created by Governor Chris Christie and led by Lieutenant Governor Kim Guadagno, the Partnership is the hub for all economic development activity in New Jersey. It is comprised of three interconnected and highly focused organizational elements, which include Choose New Jersey, Business Action Center, and EDA. The Partnership’s goals include attracting new business, and helping existing businesses thrive, in New Jersey by focusing on relationship building and person to person outreach, promoting the state's incentives and resources, developing pro-growth policies, and assisting businesses in navigating state government and programs.

     

    For additional information on the Technology Business Tax Certificate Transfer Program, visit www.njeda.com. To learn more about opportunities for business growth throughout New Jersey, visit the state's business portal at www.NewJerseyBusiness.gov

    Company Name 

    Industry 

    City 

    County 

    IGI Labs Inc.

    Biotech

    Buena

    Atlantic

    MDX Medical, Inc. (dba Vitals, Inc.)

    Tech

    Lyndhurst

    Bergen

    ADM Tronics Unlimited Inc.

    Tech

    Northvale

    Bergen

    Elite Laboratories, Inc.

    Biotech

    Northvale

    Bergen

    Millenium Biotechnologies Group, Inc.

    Biotech

    Paramus

    Bergen

    DVTel, Inc.

    Tech

    Ridgefield Park

    Bergen

    Cancer Genetics, Inc.

    Biotech

    Rutherford

    Bergen

    Circulite Inc.

    Biotech

    Teaneck

    Bergen

    Eagle Pharmaceuticals, Inc.

    Biotech

    Woodcliff Lake

    Bergen

    I.D. Systems, Inc.

    Tech

    Woodcliff Lake

    Bergen

    Ivy Sports Medicine LLC

    Biotech

    Montvale

    Bergen

    Agilence Inc.

    Biotech

    Mount Laurel

    Burlington

    Antenna Software, Inc.

    Tech

    Jersey City

    Hudson

    Voxware, Inc.

    Tech

    Hamilton

    Mercer

    Princeton Power Systems

    Tech

    Lawrenceville

    Mercer

    Ocean Power Technologies, Inc.

    Tech

    Pennington

    Mercer

    PD-LD Inc.

    Tech

    Pennington

    Mercer

    Advaxis, Inc.

    Biotech

    Princeton

    Mercer

    Agile Therapeutics

    Biotech

    Princeton

    Mercer

    Midawi Holdings

    Tech

    Princeton

    Mercer

    SightLogix, Inc.

    Tech

    Princeton

    Mercer


    Soligenix, Inc.

    Biotech

    Princeton

    Mercer

    World Water & Solar Technologies

    Tech

    Princeton

    Mercer

    Alphion Corporation

    Tech

    Princeton Junction

    Mercer

    Amicus Therapeutics, Inc.

    Biotech

    Cranbury

    Middlesex 

    Blacklight Power, inc.

    Tech

    Cranbury

    Middlesex 

    Palatin Technologies, Inc.

    Biotech

    Cranbury

    Middlesex 

    Cornerstone Pharmaceuticals

    Biotech

    Cranbury

    Middlesex 

    Oncobiologics Inc.

    Biotech

    Cranbury

    Middlesex 

    Replication Medical, Inc.

    Biotech

    Cranbury

    Middlesex 

    Vaxinnate Corporation

    Biotech

    Cranbury

    Middlesex 

    Savient Pharmaceuticals, Inc.

    Biotech

    East Brunswick

    Middlesex 

    Symbolic IO Corporation

    Tech

    Edison

    Middlesex 

    CytoSorbents, Inc.

    Biotech

    Monmouth

    Junction

    Middlesex 

    Insmed Incorporated

    Biotech

    Monmouth

    Junction

    Middlesex 

    Rive Technology, Inc.

    Tech

    Monmouth

    Junction

    Middlesex 

    TyRx Pharma, Inc.

    Biotech

    Monmouth

    Junction

    Middlesex 

    Liquid Light

    Tech

    Monmouth

    Junction

    Middlesex 

    Connotate Technologies, Inc.

    Tech

    New Brunswick

    Middlesex 

    Hemispherx Biopharma, Inc.

    Biotech

    New Brunswick

    Middlesex 

    Solidia Technologies

    Tech

    Piscataway Twp

    Middlesex 

    Innopharma, Inc.

    Biotech

    Piscataway

    Middlesex 

    iBiquity Digital Corporation

    Tech

    Piscataway

    Middlesex 

    Celator Pharmaceuticals, Inc.

    Biotech

    Plainsboro

    Middlesex 

    Angel Medical Systems, Inc.

    Biotech

    Shrewsbury

    Monmouth

    Emisphere Technologies, Inc.

    Tech

    Cedar Knolls

    Morris

    DataMotion, Inc.

    Tech

    Morristown

    Morris

    Aerie Pharmaceuticals, Inc.

    Biotech

    Bedminster

    Somerset

    Conolog Corporation

    Tech

    Branchburg

    Somerset

    VPI Systems Corporation

    Tech

    Somerset

    Somerset

    Roka Bioscience, Inc.

    Biotech

    Warren

    Somerset

    Edge Therapeutics

    Biotech

    New Providence

    Union

    Svelte Medical Systems, Inc.

    Biotech

    New Providence

    Union

    Celldex Research Corporation

    Biotech

    Phillipsburg

    Warren

  •  

    CROWDFUNDING FOR EMERGING GROWTH COMPANIES LEGISLATION IN EFFECT MONDAY, SEPTEMBER 23, 2013

    EAST BRUNSWICK, NJ (September 23, 2013) – Federal legislation intended to ease access to capital and reduce fundraising costs for emerging growth companies and small start-ups through crowdfunding went into effect today. It is part of the 2012 “Jumpstart Our Business Startups Act” known as the “JOBS Act”. Companies that qualify may seek equity investments on internet websites and social media for up to $1 million annually, with certain safeguards in place, including issuing and selling their securities only to accredited investors costly audited financial statements prepared by companies that raise more than $500,000. Final rules governing crowdfunding, however, have not yet been adopted by the United States Securities and Exchange Commission (“SEC”); similarly, the Financial Industry Regulatory Authority (“FINRA”) has not yet created a regulatory system for funding portals. The SEC has adopted new rules lifting the ban on general solicitation and advertising for certain securities offerings and is in the process of writing and adopting new rules regarding company disclosures and other safeguards, as well as rules governing funding portals. 

East Brunswick Location
Two Tower Center Blvd., 24th Floor 
East Brunswick, NJ 08816
Phone: 732.839.0400
New York City Location
515 Madison Ave., 13th Floor
New York, NY 10022
Phone: 212.600.2085
Radnor Location
4 Radnor Corporate Center, Suite 201
100 Matsonford Road
Radnor, PA  19087
Phone: 484.784.4320